RESUMO
We previously reported the anti-inflammatory activity of Lafoensia pacari extract in Toxocara canis infection, a model of systemic IL-5-dependent eosinophil migration. In the present study, we describe the kinetics of the anti-inflammatory activity of L. pacari extract and compare it with dexamethasone. T. canis-infected mice were submitted to different treatment protocols and the cells present in bronchoalveolar space and peritoneal cavity were collected at the end of each treatment period. The results showed that L. pacari extract effectively inhibited eosinophil migration only when the treatment was initiated before the peak of eosinophil migration (1st to 18th; 12th to 18th and 12th to 24th day post-infection). When eosinophil migration was established, administration of L. pacari extract had no effect on it (treatment 18th to 24th day post-infection). Dexamethasone was effective in inhibiting eosinophil migration in all periods studied. We suggest that L. pacari extract can potentially be a natural alternative treatment of eosinophilic diseases.
Assuntos
Eosinófilos/efeitos dos fármacos , Lythraceae/química , Fitoterapia , Extratos Vegetais/uso terapêutico , Toxocaríase/tratamento farmacológico , Animais , Líquido da Lavagem Broncoalveolar/citologia , Movimento Celular/efeitos dos fármacos , Dexametasona/farmacocinética , Dexametasona/farmacologia , Dexametasona/uso terapêutico , Eosinófilos/fisiologia , Feminino , Fígado/patologia , Camundongos , Cavidade Peritoneal/citologia , Casca de Planta/química , Extratos Vegetais/química , Extratos Vegetais/farmacocinética , Distribuição Aleatória , Toxocaríase/patologiaRESUMO
Toxocariasis is an infection induced by Toxocara canis, an intestinal parasite of dogs. In this study, an experimental murine model of toxocariasis was used to evaluate the anti-inflammatory activity of an ethanolic extract of Lafoensia pacari stem bark. Mice infected with T. canis were treated with L. pacari extract (200 mg/kg, p.o.). Subsequently, we observed a reduction in the number of eosinophils in the peritoneal cavity, bronchoalveolar fluid, blood and bone marrow. Production of interleukin (IL)-5, a major cytokine involved in eosinophilic differentiation, proliferation and activation, is also an important marker for infection. The reduced levels of IL-5 observed in serum, lung homogenates and bronchoalveolar fluid demonstrated the anti-inflammatory mechanisms of L. pacari. Larvae recovery from infected mice treated with L. pacari was comparable with that from untreated mice, suggesting that L. pacari is not toxic to the parasite. Nonetheless, our results demonstrate a potential therapeutic effect of L. pacari extract in IL-5-mediated inflammatory diseases and provide new prospects for the development of drugs to treat IL-5-dependent allergic diseases such as parasite infection and asthma.
Assuntos
Interleucina-5/biossíntese , Magnoliopsida , Fitoterapia , Toxocaríase/tratamento farmacológico , Animais , Células da Medula Óssea/imunologia , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Eosinófilos/imunologia , Feminino , Interleucina-5/sangue , Larva , Contagem de Leucócitos , Leucócitos Mononucleares/imunologia , Pulmão/imunologia , Camundongos , Cavidade Peritoneal/citologia , Extratos Vegetais/uso terapêutico , Toxocaríase/imunologia , Toxocaríase/parasitologiaRESUMO
We evaluated propolis influence on polyclonal activation of lymphocytes by concanavalin A (Con A). The in vitro experiments showed that propolis decreases splenocyte proliferation both in the absence or presence of Con A. The suppression in mitogen-induced splenocyte proliferation also occurred when mice were treated intraperitoneally with propolis for 3 days. An increased of IFN-gamma production in the culture supernatants of the same cells was observed. A dual action of propolis on lymphocyte activation was proposed: it decreases splenocyte proliferation in the presence or absence of Con A and stimulates IFN-gamma production by spleen cells. These results are important to understand the immunomodulatory action of propolis on the host's specific and non-specific immunity.